• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BC Platforms partners with Microsoft for artificial intelligence solutions in healthcare

BC Platforms partners with Microsoft for artificial intelligence solutions in healthcare

February 21, 2017
CenterWatch Staff

BC Platforms, a provider of genomic data management solutions, will join the Microsoft AI in Health Partner Alliance, an expanding group of partners focused on advancing health technology. This initiative includes investments in resources for Microsoft partners to capture new opportunities to apply artificial intelligence (AI) to healthcare. As part of its participation, BC Platforms will receive unique training and access to Microsoft technologies, engineering expertise and data sets. 

“BC Platforms is a leader in providing big data solutions for Healthcare and Life Science clients. In working with Microsoft, we are in a pole position to help our customers apply artificial intelligence to solve their challenges in healthcare. Our goal is to innovate to provide transformative solutions for our customers across all therapeutic areas along the product development life cycle,” said Tero Silvola, CEO at BC Platforms.

“With Microsoft, we have a possibility to build one of the world’s most powerful AI solution frameworks. We are now actively searching for university hospitals, biobanks and pharmaceutical companies to test and validate these new capabilities. We can only tackle AI challenges, large and small, by working together to solve real and concrete challenges in healthcare, explains Timo Kanninen, chief architect from BC Platforms. 

“Systems of artificial intelligence will endemically transform the way we innovate and transform for improved outcomes, the way we optimise clinical and operational processes, and the way we think and do prevention. Our vision is to work with partners across the healthcare continuum to come up with ways to improve outcomes for patients. We look forward to working with BC Platforms in this exciting and transformative journey,” commented Elena Bonfiglioli, senior director, Health Industry, Europe Middle East Africa (EMEA) at Microsoft. 

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing